Seeing Is Believing
Currently, out of the existing stock ratings of James Mainwaring - 6 which are a Hold (85.71%), 1 which are a Buy (14.29%)
Analyst James Mainwaring works at ATLANTIC EQUITIES and is covering the Healthcare sector with 14 price targets and ratings displayed on 3 stocks.
James Mainwaring's average stock forecast success ratio is 44.44% with an average time for price targets to be met of 84 days.
Most recent stock forecast was given on MDT, Medtronic plc at 01-Jun-2022.
Analyst best performing recommendations are on A (AGILENT TECHNOLOGIES).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES) at 4/12/2022. The price target of $135 was fulfilled within 127 days with a profit of $10.44 (8.38%) receiving and performance score of 0.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
150
$38.18 (34.14%)
160
1 months 14 days ago
13/19 (68.42%)
$17.89 (18.34%)
229
Buy
150
$38.18 (34.14%)
125
1 months 14 days ago
6/7 (85.71%)
$14.64 (18.27%)
266
120
$8.18 (7.32%)
124
1 months 14 days ago
6/6 (100%)
$6.72 (16.45%)
357
Buy
146
$34.18 (30.57%)
185
1 months 14 days ago
5/7 (71.43%)
$18.5 (30.18%)
530
Buy
140
$28.18 (25.20%)
144
1 months 14 days ago
8/15 (53.33%)
$17.78 (16.02%)
112
What Year was the first public recommendation made by James Mainwaring?